Search details
1.
Australian Genomics: Outcomes of a 5-year national program to accelerate the integration of genomics in healthcare.
Am J Hum Genet
; 110(3): 419-426, 2023 03 02.
Article
in English
| MEDLINE | ID: mdl-36868206
2.
Oncomicrobial Community Profiling Identifies Clinicomolecular and Prognostic Subtypes of Colorectal Cancer.
Gastroenterology
; 165(1): 104-120, 2023 Jul.
Article
in English
| MEDLINE | ID: mdl-36933623
3.
Colon and rectal cancer treatment patterns and their associations with clinical, sociodemographic and lifestyle characteristics: analysis of the Australian 45 and Up Study cohort.
BMC Cancer
; 23(1): 60, 2023 Jan 18.
Article
in English
| MEDLINE | ID: mdl-36650482
4.
The predicted effect and cost-effectiveness of tailoring colonoscopic surveillance according to mismatch repair gene in patients with Lynch syndrome.
Genet Med
; 24(9): 1831-1846, 2022 09.
Article
in English
| MEDLINE | ID: mdl-35809086
5.
Implementing gene curation for hereditary cancer susceptibility in Australia: achieving consensus on genes with clinical utility.
J Med Genet
; 58(12): 853-858, 2021 12.
Article
in English
| MEDLINE | ID: mdl-33168572
6.
The complexities, coordination, culture and capacities that characterise the delivery of oncology services in the common areas of ambulatory settings.
BMC Health Serv Res
; 22(1): 190, 2022 Feb 12.
Article
in English
| MEDLINE | ID: mdl-35151314
7.
Challenges in valuing and paying for combination regimens in oncology: reporting the perspectives of a multi-stakeholder, international workshop.
BMC Health Serv Res
; 21(1): 412, 2021 May 03.
Article
in English
| MEDLINE | ID: mdl-33941174
8.
Tumour infiltrating lymphocyte status is superior to histological grade, DNA mismatch repair and BRAF mutation for prognosis of colorectal adenocarcinomas with mucinous differentiation.
Mod Pathol
; 33(7): 1420-1432, 2020 07.
Article
in English
| MEDLINE | ID: mdl-32047231
9.
The predicted impact and cost-effectiveness of systematic testing of people with incident colorectal cancer for Lynch syndrome.
Med J Aust
; 212(2): 72-81, 2020 02.
Article
in English
| MEDLINE | ID: mdl-31595523
10.
What are the attitudes of health professionals regarding patient reported outcome measures (PROMs) in oncology practice? A mixed-method synthesis of the qualitative evidence.
BMC Health Serv Res
; 20(1): 102, 2020 Feb 10.
Article
in English
| MEDLINE | ID: mdl-32041593
11.
Lymphocytic response to tumour and deficient DNA mismatch repair identify subtypes of stage II/III colorectal cancer associated with patient outcomes.
Gut
; 68(3): 465-474, 2019 03.
Article
in English
| MEDLINE | ID: mdl-29382774
12.
Evaluation of the transferability of survival calculators for stage II/III colon cancer across healthcare systems.
Int J Cancer
; 145(1): 132-142, 2019 07 01.
Article
in English
| MEDLINE | ID: mdl-30620048
13.
PDGF-AB and 5-Azacytidine induce conversion of somatic cells into tissue-regenerative multipotent stem cells.
Proc Natl Acad Sci U S A
; 113(16): E2306-15, 2016 Apr 19.
Article
in English
| MEDLINE | ID: mdl-27044077
14.
Survival outcomes for Australian women receiving trastuzumab for HER2-positive metastatic breast cancer following (neo)adjuvant trastuzumab: a national population-based observational study (2006-2014).
Br J Cancer
; 118(3): 441-447, 2018 02 06.
Article
in English
| MEDLINE | ID: mdl-29136405
15.
Long-term survival in trastuzumab-treated patients with HER2-positive metastatic breast cancer: real-world outcomes and treatment patterns in a whole-of-population Australian cohort (2001-2016).
Breast Cancer Res Treat
; 171(1): 151-159, 2018 Aug.
Article
in English
| MEDLINE | ID: mdl-29736743
16.
Cost-effectiveness analysis of germ-line BRCA testing in women with breast cancer and cascade testing in family members of mutation carriers.
Genet Med
; 20(9): 985-994, 2018 09.
Article
in English
| MEDLINE | ID: mdl-29300376
17.
Factors associated with participation in colorectal cancer screening in Australia: Results from the 45 and Up Study cohort.
Prev Med
; 106: 185-193, 2018 01.
Article
in English
| MEDLINE | ID: mdl-29109015
18.
Understanding the Pathogenicity of Noncoding Mismatch Repair Gene Promoter Variants in Lynch Syndrome.
Hum Mutat
; 37(5): 417-26, 2016 May.
Article
in English
| MEDLINE | ID: mdl-26888055
19.
A cryptic paracentric inversion of MSH2 exons 2-6 causes Lynch syndrome.
Carcinogenesis
; 37(1): 10-17, 2016 Jan.
Article
in English
| MEDLINE | ID: mdl-26498247
20.
The Impact of Mismatch Repair Status in Colorectal Cancer on the Decision to Treat With Adjuvant Chemotherapy: An Australian Population-Based Multicenter Study.
Oncologist
; 21(5): 618-25, 2016 05.
Article
in English
| MEDLINE | ID: mdl-27009937